Showing results (1301-1310 of 1,806) with videos related to
Sort By:
Pageof 181
Lipids|December 1, 1991
Cardiovascular effects of platelet-activating factorR E Goldstein, G Z Feuerstein, L M Bradley, et al.BMJ Open|July 7, 2020
Breast cancer application protocol: a randomised controlled trial to evaluate a self-management app for breast cancer survivorsAndy S K Cheng, Xiangyu Liu, Peter H F Ng, et al.Acta Biologica Et Medica Germanica|January 1, 1981
Defined rearrangement of the membrane of banked erythrocytesK J Halbhuber, D Stibenz, H Feuerstein, et al.The Journal of Clinical Investigation|May 1, 1992
Platelet activating factor mediates interleukin-2-induced lung injury in the ratR Rabinovici, M D Sofronski, J F Renz, et al.The American Journal of Pathology|March 10, 2001
Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groupsY Hirose, K Aldape, A Bollen, et al.British Journal of Pharmacology|March 7, 1998
Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injuryT A Christopher, B L Lopez, X L Ma, et al.Thrombosis Research|October 29, 2000
Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparin in a rat model of arterial thrombosisJ R Toomey, M N Blackburn, B L Storer, et al.Biochimica Et Biophysica Acta|October 2, 1996
Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayersH Y Cheng, C S Randall, W W Holl, et al.The American Journal of Surgical Pathology|October 1, 1993
Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 casesW D Travis, Z Borok, J H Roum, et al.Transplantation|July 17, 2003
Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injuryM Patricia Castaneda, Agnieszka Swiatecka-Urban, Mark M Mitsnefes, et al.Pageof 181